These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 23486332)

  • 1. Markedly increased 18F-FDG uptake in a nonfunctioning adrenal adenoma mimicking malignancy.
    Treglia G; Oragano L; Fadda G; De Gaetano AM; Raffaelli M; Rufini V
    Clin Nucl Med; 2013 Aug; 38(8):e333-5. PubMed ID: 23486332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rare case of solitary fibrous tumor of the adrenal gland detected by (18)F-FDG PET/CT.
    Treglia G; Oragano L; Fadda G; Raffaelli M; Lombardi CP; Castaldi P; Rufini V
    Clin Nucl Med; 2014 May; 39(5):475-7. PubMed ID: 23640229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging of adrenal incidentalomas with PET using (11)C-metomidate and (18)F-FDG.
    Minn H; Salonen A; Friberg J; Roivainen A; Viljanen T; Långsjö J; Salmi J; Välimäki M; Någren K; Nuutila P
    J Nucl Med; 2004 Jun; 45(6):972-9. PubMed ID: 15181132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A black adrenal adenoma difficult to be differentiated from a malignant adrenal tumor by CT, MRI, scintigraphy and FDG PET/CT examinations.
    Nakajo M; Nakajo M; Kajiya Y; Tani A; Tsuruta M; Sugita S; Fushitani S; Umekita Y
    Ann Nucl Med; 2011 Dec; 25(10):812-7. PubMed ID: 21918842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenal-to-liver SUV ratio is the best parameter for differentiation of adrenal metastases from adenomas using 18F-FDG PET/CT.
    Watanabe H; Kanematsu M; Goshima S; Kondo H; Kawada H; Noda Y; Moriyama N
    Ann Nucl Med; 2013 Aug; 27(7):648-53. PubMed ID: 23625579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of lipid-rich adrenal tumors by FDG PET/CT: Are they hormone-secreting or not?
    Takanami K; Kaneta T; Morimoto R; Satoh F; Nakamura Y; Takase K; Takahashi S
    Ann Nucl Med; 2014 Feb; 28(2):145-53. PubMed ID: 24272068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benign hormone-secreting adenoma within a larger adrenocortical mass showing intensely increased activity on
    Papadakis GZ; Millo C; Stratakis CA
    Endocrine; 2016 Oct; 54(1):269-270. PubMed ID: 27154873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 18F-FDG Uptake in Benign Fibrous Histiocytoma of Adrenal Gland: A Potential Pitfall.
    Tan TH; Lai CNB
    Clin Nucl Med; 2017 Aug; 42(8):622-623. PubMed ID: 28632691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total lesion glycolysis as the best 18F-FDG PET/CT parameter in differentiating intermediate-high risk adrenal incidentaloma.
    Kim YI; Cheon GJ; Paeng JC; Cho JY; Kang KW; Chung JK; Kim EE; Lee DS
    Nucl Med Commun; 2014 Jun; 35(6):606-12. PubMed ID: 24598843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. False positive 18F-FDG PET scan in adrenal oncocytoma.
    Acar C; Akkas BE; Sen I; Sozen S; Kitapci MT
    Urol Int; 2008; 80(4):444-7. PubMed ID: 18587259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging characterization of non-hypersecreting adrenal masses. Comparison between MR and radionuclide techniques.
    Maurea S; Caracò C; Klain M; Mainolfi C; Salvatore M
    Q J Nucl Med Mol Imaging; 2004 Sep; 48(3):188-97. PubMed ID: 15499292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation of an adrenal mass in patients with non-small cell lung cancer by means of a normal range of adrenal standardized uptake values on FDG PET/CT.
    Kim BS; Lee JD; Kang WJ
    Ann Nucl Med; 2015 Apr; 29(3):276-83. PubMed ID: 25480483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peritoneal carcinomatosis: role of (18)F-FDG PET.
    Turlakow A; Yeung HW; Salmon AS; Macapinlac HA; Larson SM
    J Nucl Med; 2003 Sep; 44(9):1407-12. PubMed ID: 12960184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 18F-FDG PET in characterizing adrenal lesions detected on CT or MRI.
    Yun M; Kim W; Alnafisi N; Lacorte L; Jang S; Alavi A
    J Nucl Med; 2001 Dec; 42(12):1795-9. PubMed ID: 11752075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiating adrenal adenomas from nonadenomas using (18)F-FDG PET/CT: quantitative and qualitative evaluation.
    Caoili EM; Korobkin M; Brown RK; Mackie G; Shulkin BL
    Acad Radiol; 2007 Apr; 14(4):468-75. PubMed ID: 17368217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pitfalls in the diagnosis of pheochromocytoma.
    Connor CS; Hermreck AS; Thomas JH
    Am Surg; 1988 Oct; 54(10):634-6. PubMed ID: 3178050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative imaging characterization of hypersecreting or nonhypersecreting adrenal adenomas: comparison between iodine-131 norcholesterol uptake and magnetic resonance signal intensity ratios.
    Maurea S; Imbriaco M; Mollica C; Pace L; Salvatore M
    Nucl Med Commun; 2011 Jun; 32(6):535-41. PubMed ID: 21448089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. F-18 FDG-avid intrathyroidal parathyroid adenoma mimicking follicular neoplasm.
    Kim MK; Kim GS; Kim SY; Baek KH; Kang MI; Lee KW; Sohn HS; Park WC; Song KH
    Clin Nucl Med; 2009 Mar; 34(3):178-9. PubMed ID: 19352286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18F-FDG PET/CT in the evaluation of adrenal masses.
    Metser U; Miller E; Lerman H; Lievshitz G; Avital S; Even-Sapir E
    J Nucl Med; 2006 Jan; 47(1):32-7. PubMed ID: 16391184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leiomyoma Originated From Inferior Vena Cava Mimicking an Adrenal Malignant Tumor on 18F-FDG PET/CT.
    Fu Z; Liu M; Li Z; Zhang J; Li Q
    Clin Nucl Med; 2017 Jul; 42(7):558-559. PubMed ID: 28263218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.